Healthcare -
Biotechnology - NASDAQ - US
$ 26.5
0.607 %
$ 2.22 B
Market Cap
-5.79
P/E
BEAM - OPERATING EXPENSES
Operating Expenses BEAM - Beam Therapeutics Inc.
554 M
LAST VALUE
11.68%
2 YEAR CAGR
64.69%
5 YEAR CAGR
0.00%
10 YEAR CAGR